用梯牧草过敏原提取物进行免疫疗法会引起对混合草过敏原提取物的免疫反应。

Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract.

机构信息

Allergy Department, Hospital Clínico Universitario San Carlos, Madrid, Spain.

出版信息

J Investig Allergol Clin Immunol. 2010;20(1):13-9.

DOI:
Abstract

BACKGROUND

Grass pollen allergy is one of the most common allergies worldwide, and patients often show sensitization to an array of phylogenetically related species.

OBJECTIVE

To determine the effect of specific immunotherapy (SIT) with Phleum pratense extract on induction of the immune response to a mixture composed of 5 grass pollen extracts.

METHODS

Forty-six adult patients suffering from rhinitis and sensitized to a mix of grass pollen allergen extracts were randomized 3:1 to receive a short course of SIT with P. pratense or to an open control group without SIT. At baseline and after 3-4 months, we evaluated levels of specific immunoglobulin (Ig) E and IgG4, as well as the immediate and delayed cutaneous responses to the grass mix and P. pratense. IgG4 to Lolium perenne was also determined.

RESULTS

Levels of IgE and IgG4 to grass mix and P. pratense increased significantly during treatment (P<.001). However, this increase was only significantly higher in the SIT group than in the control group for IgG4 (P<.001). The levels of IgG4 to Phl p 5 and Lol p 5 were highly correlated (r=0.99, P<.001). The immediate and delayed cutaneous responses were significantly diminished to both extracts after SIT (P<.001).

CONCLUSIONS

Patients with rhinoconjunctivitis diagnosed using skin prick testing with a grass mix allergen extract and treated with a short course of SIT based on a single species P. pratense allergen extract are able to develop an immune response that targets not only the immunizing species, but also the grass mix allergen extract.

摘要

背景

草花粉过敏是世界上最常见的过敏症之一,患者通常对一系列系统发育相关的物种产生致敏。

目的

确定草花粉提取物的特异性免疫治疗(SIT)对由 5 种草花粉提取物组成的混合物诱导免疫反应的影响。

方法

46 名患有鼻炎且对草花粉过敏原混合物敏感的成年患者被随机分为 3:1 接受 Phleum pratense 提取物的短期 SIT 治疗或接受无 SIT 的开放对照组。在基线和 3-4 个月后,我们评估了特异性免疫球蛋白(Ig)E 和 IgG4 的水平,以及对草混合物和 Phleum pratense 的即刻和延迟皮肤反应。还测定了 Lolium perenne 的 IgG4。

结果

在治疗过程中,IgE 和 IgG4 对草混合物和 Phleum pratense 的水平显著增加(P<.001)。然而,与对照组相比,SIT 组 IgG4 的增加仅显著更高(P<.001)。Phl p 5 和 Lol p 5 的 IgG4 水平高度相关(r=0.99,P<.001)。SIT 后,对两种提取物的即刻和延迟皮肤反应均显著减弱(P<.001)。

结论

通过草花粉混合物过敏原提取物进行皮肤点刺试验诊断为鼻结膜炎,并接受基于单一物种 Phleum pratense 过敏原提取物的短期 SIT 治疗的患者能够产生针对不仅免疫原性物种,而且还针对草花粉混合物过敏原提取物的免疫反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索